IXC 2.86% 7.2¢ invex therapeutics ltd

Read this in The Times in the UK with excitement, and then...

  1. 190 Posts.
    lightbulb Created with Sketch. 22
    Read this in The Times in the UK with excitement, and then alarm. https://www.thetimes.co.uk/edition/news/common-diabetes-drug-may-be-treatment-for-parkinson-s-disease-xhz3cvtzx

    Forgive me if I am loose on the details - but I read here that University College of London are about to launch a phase III trial into Parkinson's Disease using Exenitide.

    I believe Exenitide is the same drug IXC are re-purposing for IIH. Is this correct?

    If so, I thought we had global patent over it's use for several purposes not just IIH?

    I assume IXC is playing no role in this study?
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.0¢ 7.2¢ 6.6¢ $3.476K 50.58K

Buyers (Bids)

No. Vol. Price($)
1 29320 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 13.58pm 23/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.